Skip to main content
Explore URMC
menu

Monica Javidnia, Ph.D.

Publications

Showing all 7 journal articles & 0 books available

Journal Articles

5/15/2020
Javidnia M, Shoulson I, Kieburtz K, Venuto C. "Pharmacotherapy Use for Non-Motor Symptoms Among de novo Parkinson's Disease Parkinson's Progression Markers Initiative Participants." Journal of Parkinson's disease.. 2020 May 15; Epub 2020 May 15.

1/1/2020
Javidnia M, Frasier M, Shoulson I, Turkoz I, Budur K. "Innovative Approaches for Slowing Disease Progression in Parkinson's Disease: Takeaways from the 14th Annual International Society for Central Nervous System Clinical Trials and Methodology Scientific Meeting." . 2020 Jan 1; 17(1-3):14-19.

2019
Merchant KM, Cedarbaum JM, Brundin P, Dave KD, Eberling J, Espay AJ, Hutten SJ, Javidnia M, Luthman J, Maetzler W, Menalled L, Reimer AN, Stoessl AJ, Weiner DM, . "A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein." Journal of Parkinson's disease.. 2019 9(1):31-61.

8/15/2018
Hebron ML, Javidnia M, Moussa CE. "Tau clearance improves astrocytic function and brain glutamate-glutamine cycle." Journal of the neurological sciences.. 2018 Aug 15; 391:90-99. Epub 2018 Jun 12.

2017
Javidnia M, Hebron ML, Xin Y, Kinney NG, Moussa CE. "Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy." Journal of Alzheimer's disease : JAD.. 2017 60(2):461-481.

9/2015
DiRaddo JO, Miller EJ, Bowman-Dalley C, Wroblewska B, Javidnia M, Grajkowska E, Wolfe BB, Liotta DC, Wroblewski JT. "Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors." Molecular pharmacology.. 2015 Sep 0; 88(3):450-9. Epub 2015 Jun 18.

10/9/2013
Kokkinaki M, Abu-Asab M, Gunawardena N, Ahern G, Javidnia M, Young J, Golestaneh N. "Klotho regulates retinal pigment epithelial functions and protects against oxidative stress." The Journal of neuroscience : the official journal of the Society for Neuroscience.. 2013 Oct 9; 33(41):16346-59.